North America Pediatric Respiratory Disease Therapeutics Market Outlook: Steady Growth to 2034
North America holds a significant share of the pediatric respiratory disease therapeutics market, driven by the high prevalence of respiratory disorders such as asthma, respiratory syncytial virus (RSV) infections, pneumonia, and cystic fibrosis among children. The region benefits from a well-established healthcare infrastructure, widespread access to advanced diagnostic technologies, and...
0 التعليقات 0 المشاركات 427 مشاهدة 0 معاينة